Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by MarketMoneyon Dec 06, 2021 1:25pm
114 Views
Post# 34202821

RE:RE:RE:RE:RE:RE:NATIONAL

RE:RE:RE:RE:RE:RE:NATIONAL
LithLover wrote: That would be a whole other deal. The covid testing is just to provide additional revenue until Aristotle goes international.

Rexall, Sobeys, Safeway is a great start.  Ichor is not in Quebec and than you need french speaking people to witness the test as well.  Not saying it won't or current happen.

But many are missing the point.  Rolling out Safeway and Sobeys is a nice revnue bump and than what Tyler found with the upcoming opening of Aristotle testing in the entire US is a game changer.    

The network of Quest Diagnostics, Phleb-finders and others is going to pay off with the national roll out of Aristotle in the US.  This at home ciovid testing is a nice add but the real money is about to come.


MarketMoney wrote: And if I was in the shoes of the CEO I would step in the Province of quebec as it's the second largest population in Canada. Everytime I see news from SZLS in Canada I always feel this Province is let alone but why? There's so much money to make here also!




yes it's all great news!!

What I was refering was the question below about Province of Quebec and testing....when you deal with others local bussiness your own employee don't need to speech french for the blood draw (Aristotle) or COVID testing because the local speech french and they send the sample to SZLS lab :-) 

In other words, the sample is not french or english....it's a sample so you don't need to speech the language to ship it :-)

<< Previous
Bullboard Posts
Next >>